Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J. 2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.
Bioorg Med Chem Lett 1999;
9:91-6. [PMID:
9990463 DOI:
10.1016/s0960-894x(98)00691-x]
[Citation(s) in RCA: 68] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Novel 2,6,9-substituted purine derivatives represent a class of potent and selective inhibitors of CDK1/cyclinB. The synthesis, SAR and biological profile of selected compounds are described.
Collapse